BGC20-761
BGC20-761 is an experimental drug which acts as an antagonist of the 5-HT6, 5-HT2 family, and dopamine D2 receptors, with strongest affinity for 5-HT6. In animal studies it has antipsychotic-like effects, but also memory enhancing action attributed to its 5-HT6 affinity.